Non-small cell lung cancer: Clinical practice guidelines in oncology

Academic Article


  • Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion. © JNCCN-Journal of the National Comprehensive Cancer Network.
  • Digital Object Identifier (doi)

    Author List

  • Ettinger DS; Akerley W; Borghaei H; Chang AC; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AKP; Govindan R
  • Start Page

  • 1236
  • End Page

  • 1271
  • Volume

  • 10
  • Issue

  • 10